<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="88865">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01684852</url>
  </required_header>
  <id_info>
    <org_study_id>PPL-046</org_study_id>
    <secondary_id>NIS BAT04</secondary_id>
    <nct_id>NCT01684852</nct_id>
  </id_info>
  <brief_title>Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution</brief_title>
  <official_title>Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution (BAT04) Compared to HA Eye Drops in the Treatment of Dry Eye Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bitop AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bitop AG</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a comparative, open label, parallel group, non interventional study to further
      demonstrate the efficacy and tolerability of BAT04. In addition the efficacy and safety
      shall be compared to Hyaluronic acid (HA)-Product. The patient applies BAT04 or HA-Product
      according to the instructions for use six times daily in both eyes over a period of 28 days.
      Response to treatment is recorded at day 28.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Tear Break Up Time</measure>
    <time_frame>V1 and V2</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">64</enrollment>
  <condition>Dry Eye Syndromes</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical device, drug-like</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic The selection of appropriate patients for the observational study is
        made by the individual physician in his treatment decisions in consultation with the
        individual patient
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female person aged 18 years

          -  Demonstrated mild to moderate keratoconjunctivitis sicca (​​&quot;dry eye&quot;)

          -  Acute symptoms of dry eye: DEWS 1-3

          -  tear break-up time TBUT &lt;10s

          -  agreement to abide by the routinely provided doctor's appointment for follow-up
             (reflected in the planned visits of observation plan resist)

        Exclusion Criteria:

          -  inflammation of the anterior segment or trauma

          -  Contact lens wearers

          -  Any disease that can, in the opinion of the treating physician to affect the outcome
             of the study.

          -  Patients with known intolerance to one of the substances used

          -  Surgical procedures to the eyes in the last 6 weeks before inclusion in the trial

          -  patients with addictive disorders or substance abuse fallow in the past 12 months, as
             well as persons incapable of giving consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisabeth Messmer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augenklinik der LMU Klinikum der Universität München</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Peter Otto</name>
      <address>
        <city>Bad Liebenwerda</city>
        <zip>04924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Insa Beddermann</name>
      <address>
        <city>Duderstadt</city>
        <zip>37115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augenklinik mit Poliklinik</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augenklinik der LMU Klinikum der Universität Muenchen</name>
      <address>
        <city>Muenchen</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augenabteilung am St. Franziskus-Hospital Münster</name>
      <address>
        <city>Muenster</city>
        <zip>48145</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 29, 2013</lastchanged_date>
  <firstreceived_date>September 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dry eye, sicca, HA, Hyaluronic Acid, ectoin, ectoine, bitop</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
